167 related articles for article (PubMed ID: 12654311)
1. Targeting the MraY and MurG bacterial enzymes for antimicrobial therapeutic intervention.
Zawadzke LE; Wu P; Cook L; Fan L; Casperson M; Kishnani M; Calambur D; Hofstead SJ; Padmanabha R
Anal Biochem; 2003 Mar; 314(2):243-52. PubMed ID: 12654311
[TBL] [Abstract][Full Text] [Related]
2. Scintillation proximity assay for inhibitors of Escherichia coli MurG and, optionally, MraY.
Ravishankar S; Kumar VP; Chandrakala B; Jha RK; Solapure SM; de Sousa SM
Antimicrob Agents Chemother; 2005 Apr; 49(4):1410-8. PubMed ID: 15793120
[TBL] [Abstract][Full Text] [Related]
3. Assay for identification of inhibitors for bacterial MraY translocase or MurG transferase.
Branstrom AA; Midha S; Longley CB; Han K; Baizman ER; Axelrod HR
Anal Biochem; 2000 May; 280(2):315-9. PubMed ID: 10790316
[TBL] [Abstract][Full Text] [Related]
4. High-throughput screen for inhibitors of transglycosylase and/or transpeptidase activities of Escherichia coli penicillin binding protein 1b.
Chandrakala B; Shandil RK; Mehra U; Ravishankar S; Kaur P; Usha V; Joe B; deSousa SM
Antimicrob Agents Chemother; 2004 Jan; 48(1):30-40. PubMed ID: 14693515
[TBL] [Abstract][Full Text] [Related]
5. Identification of novel inhibitors of phospho-MurNAc-pentapeptide translocase MraY from library screening: Isoquinoline alkaloid michellamine B and xanthene dye phloxine B.
Mihalyi A; Jamshidi S; Slikas J; Bugg TD
Bioorg Med Chem; 2014 Sep; 22(17):4566-71. PubMed ID: 25127465
[TBL] [Abstract][Full Text] [Related]
6. The essential peptidoglycan glycosyltransferase MurG forms a complex with proteins involved in lateral envelope growth as well as with proteins involved in cell division in Escherichia coli.
Mohammadi T; Karczmarek A; Crouvoisier M; Bouhss A; Mengin-Lecreulx D; den Blaauwen T
Mol Microbiol; 2007 Aug; 65(4):1106-21. PubMed ID: 17640276
[TBL] [Abstract][Full Text] [Related]
7. Structural insights into inhibition of lipid I production in bacterial cell wall synthesis.
Chung BC; Mashalidis EH; Tanino T; Kim M; Matsuda A; Hong J; Ichikawa S; Lee SY
Nature; 2016 May; 533(7604):557-560. PubMed ID: 27088606
[TBL] [Abstract][Full Text] [Related]
8. E. Coli MurG: a paradigm for a superfamily of glycosyltransferases.
Ha S; Gross B; Walker S
Curr Drug Targets Infect Disord; 2001 Aug; 1(2):201-13. PubMed ID: 12455415
[TBL] [Abstract][Full Text] [Related]
9. A high-throughput solid-phase extraction assay capable of measuring diverse polyprenyl phosphate: sugar-1-phosphate transferases as exemplified by the WecA, MraY, and MurG proteins.
Hyland SA; Anderson MS
Anal Biochem; 2003 Jun; 317(2):156-65. PubMed ID: 12758253
[TBL] [Abstract][Full Text] [Related]
10. Identification of active-site inhibitors of MurG using a generalizable, high-throughput glycosyltransferase screen.
Helm JS; Hu Y; Chen L; Gross B; Walker S
J Am Chem Soc; 2003 Sep; 125(37):11168-9. PubMed ID: 16220917
[TBL] [Abstract][Full Text] [Related]
11. Acceptor specificity and inhibition of the bacterial cell-wall glycosyltransferase MurG.
Liu H; Ritter TK; Sadamoto R; Sears PS; Wu M; Wong CH
Chembiochem; 2003 Jul; 4(7):603-9. PubMed ID: 12851929
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of phospho-MurNAc-pentapeptide translocase (MraY) by nucleoside natural product antibiotics, bacteriophage ϕX174 lysis protein E, and cationic antibacterial peptides.
Bugg TD; Rodolis MT; Mihalyi A; Jamshidi S
Bioorg Med Chem; 2016 Dec; 24(24):6340-6347. PubMed ID: 27021004
[TBL] [Abstract][Full Text] [Related]
13. An assay for exogenous sources of purified MurG, enabled by the complementation of Escherichia coli murG(Ts) by the Mycobacterium tuberculosis homologue.
Jha RK; Katagihallimath N; Hota SK; Das KS; de Sousa SM
FEMS Microbiol Lett; 2012 Jan; 326(2):161-7. PubMed ID: 22092490
[TBL] [Abstract][Full Text] [Related]
14. Identification of selective inhibitors for the glycosyltransferase MurG via high-throughput screening.
Hu Y; Helm JS; Chen L; Ginsberg C; Gross B; Kraybill B; Tiyanont K; Fang X; Wu T; Walker S
Chem Biol; 2004 May; 11(5):703-11. PubMed ID: 15157881
[TBL] [Abstract][Full Text] [Related]
15. Development of a microplate-based scintillation proximity assay for MraY using a modified substrate.
Solapure SM; Raphael P; Gayathri CN; Barde SP; Chandrakala B; Das KS; De Sousa SM
J Biomol Screen; 2005 Mar; 10(2):149-56. PubMed ID: 15799958
[TBL] [Abstract][Full Text] [Related]
16. A multitarget assay for inhibitors of membrane-associated steps of peptidoglycan biosynthesis.
Barbosa MD; Ross HO; Hillman MC; Meade RP; Kurilla MG; Pompliano DL
Anal Biochem; 2002 Jul; 306(1):17-22. PubMed ID: 12069409
[TBL] [Abstract][Full Text] [Related]
17. Insights into the Target Interaction of Naturally Occurring Muraymycin Nucleoside Antibiotics.
Koppermann S; Cui Z; Fischer PD; Wang X; Ludwig J; Thorson JS; Van Lanen SG; Ducho C
ChemMedChem; 2018 Apr; 13(8):779-784. PubMed ID: 29438582
[TBL] [Abstract][Full Text] [Related]
18. Identification of a novel inhibition site in translocase MraY based upon the site of interaction with lysis protein E from bacteriophage ϕX174.
Rodolis MT; Mihalyi A; O'Reilly A; Slikas J; Roper DI; Hancock RE; Bugg TD
Chembiochem; 2014 Jun; 15(9):1300-8. PubMed ID: 24895118
[TBL] [Abstract][Full Text] [Related]
19. The biosynthesis of peptidoglycan lipid-linked intermediates.
Bouhss A; Trunkfield AE; Bugg TD; Mengin-Lecreulx D
FEMS Microbiol Rev; 2008 Mar; 32(2):208-33. PubMed ID: 18081839
[TBL] [Abstract][Full Text] [Related]
20. Fluorescence detection-based functional assay for high-throughput screening for MraY.
Stachyra T; Dini C; Ferrari P; Bouhss A; van Heijenoort J; Mengin-Lecreulx D; Blanot D; Biton J; Le Beller D
Antimicrob Agents Chemother; 2004 Mar; 48(3):897-902. PubMed ID: 14982781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
